AdventHealth Tampa Enrolls First Patient in the Tectonic CAD IVL Trial

On September 19, 2025, AdventHealth Tampa successfully enrolled its first patient in the Tectonic CAD Intravascular Lithotripsy (IVL) Trial, led by Dr. Mahmaljy and his team.

This IDE clinical trial evaluates Abbott’s Coronary IVL System, an innovative technology that uses sound pressure waves to break up severe calcium deposits in coronary arteries before stent placement. The system represents a promising advancement in the treatment of complex coronary artery disease.

A sincere thank you to the entire team for their dedication and enthusiasm in supporting this important research initiative.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

Advancing Cancer Research Closer to Home

At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...

News

Moving More, Managing Better

For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.

News

The Power of Participation

Before new diabetes technologies reach patients… before new treatments improve daily life… before researchers better understand diseases like Type 1 diabetes (T1D)… someone has to volunteer for the...